NCT01833585

Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells

Pilot Study of Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Mahidol University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the safety and efficacy of G-CSF-mobilized autologous peripheral blood mononuclear cell injection to ischemic limbs of patients with critical limb ischemia.

Conditions

• Critical Limb Ischemia
• Atherosclerosis
• Ischemic Ulcer
• Gangrene

Interventions

Type	Name	Description
BIOLOGICAL	Peripheral blood mononuclear cell	Peripheral blood mononuclear cell solution 59 cc will be injected to the gastrocnemius muscle of ischemic limb of patients with critical limb ischemia

Timeline

• Start date: 2013-04-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2013-04-17
• Last updated: 2018-08-17

Locations

1 site across 1 country: Thailand